BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0001 (-50.00%)
At close: Nov 4, 2026

BioRegenx Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
0129---
Market Cap Growth
-99.25%44.15%----
Enterprise Value
21511---
Last Close Price
0.000.010.01---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.066.693.68---
PB Ratio
--2.73-2.55---
P/FCF Ratio
5.15414.83----
P/OCF Ratio
3.48318.43----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
1.267.884.57---
EV/FCF Ratio
117.60488.63----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.48-0.49-0.64-0.72-0.90-1.07
Debt / FCF Ratio
114.8874.03----
Net Debt / Equity Ratio
-0.47-0.47-0.62-0.66-0.56-0.80
Net Debt / EBITDA Ratio
-7.05-4.83-0.49-0.40-0.54-0.81
Net Debt / FCF Ratio
112.4571.71-4.10-0.90-0.48-0.66
Asset Turnover
4.314.033.412.731.372.10
Inventory Turnover
2.743.224.153.541.511.90
Quick Ratio
0.020.030.020.080.200.30
Current Ratio
0.050.060.090.230.520.63
Return on Assets (ROA)
-57.36%-70.55%-595.83%-170.60%-66.39%-106.97%
Return on Capital Employed (ROCE)
10.30%14.20%209.60%177.40%130.30%303.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1353.00%-12.44%-267.80%---
FCF Yield
19.40%0.24%-5.96%---
Buyback Yield / Dilution
-0.32%-5.19%-42.61%-1588.74%-7.42%-1.01%